Pathogenetic significance of intestinal Candida colonization: Communication from the "Methods and Quality Assurance in Environmental Medicine" Commission of the Robert Koch Institute;Pathogenetische Bedeutung der intestinalen Candidabesiedelung: Mitteilung der Kommission "Methoden und Qualitätssicherung in der Umweltmedizin" des Robert Koch-Instituts

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 47, Issue 6, 2004, Pages 587-600

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM; ENVIRONMENTAL DISEASE; GASTROINTESTINAL DISEASE; GERMANY; HEALTH SURVEY; HUMAN; MICROBIOLOGY; OPPORTUNISTIC INFECTION; ORGANIZATION; PATHOGENICITY; RISK; SYNDROME; VIRULENCE;

ACADEMIES AND INSTITUTES; CANDIDA ALBICANS; CANDIDIASIS; CROSS-SECTIONAL STUDIES; DIGESTIVE SYSTEM; ENVIRONMENTAL ILLNESS; GASTROINTESTINAL DISEASES; GERMANY; HEALTH SURVEYS; HUMANS; OPPORTUNISTIC INFECTIONS; RISK; SYNDROME; VIRULENCE;

EID: 4444264479     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-004-0860-1     Document Type: Article

References (198)

1. Anaissie EJ, McGinnis MR, Pfaller MA et al. (2003) Clinical Mycology. Churchill Living-stone/Elsevier Science, New York, Edinburg, London, Philadelphia
2. Bodey GP (Hrsg) (1993) Candidiasis: pathogen-esis, diagnosis, and treatment. Raven Press, New York
3. Calderone RA (Hrsg) (2002) Candida und Candidiasis. ASM Press, Washington, D.C
4. Edwards JE (2000) Candida species. In: Mandell D, Bennett JE, Dolin R (Hrsg) Principles and Practice of Infectious Diseases. Churchill Livingstone, New York, S 2656
5. Gemeinhardt H (Hrsg) (1989) Endomykosen. Gustav Fischer Verlag, Stuttgart, New York
6. Hof H (2003) Mykologie für Mediziner. Thieme, Stuttgart, New York
7. Müller J (1978) Mikroökologisch-quantitative Studien über die Sproßpilzflora des Menschen. Habilitationsschrift. Med. Fakultät, Universität Freiburg i. Br.
8. Odds FC (1988) Candida and candidosis. A review and bibliography. Baillière Tindall, London, Philadelphia, Toronto
9. Rippon JW (1988) Medical mycology. The pathogenic fungi and the pathogenic actino-mycetes. W.B. Saunders, Philadelphia, London
10. Rupec J, Korting HC (2003) Candida-Infektion. In: Plettenberg A, Meigel W (Hrsg) Dermatologische Infektiologie. Blackwell, Berlin - Wien, S 222-232
11. Ruhnke M (Hrsg) (2003) Pilzinfektionen bei immunsupprimierten Patienten. UNI-MED, Bremen, London, Boston
12. Alberti C, Brun-Buisson C, Burchardi H et al. (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108-121
13. British Society for Antimicrobial Chemotherapy Working Party (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20:522-528
14. Dean DA, Burchard KW (1996) Fungal infection in surgical patients. Am J Surg 171:374-382
15. Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lan-cet Infect Dis 3:685-702
16. Hedderwick SA, Lyons MJ, Liu M et al.(2000) Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 19:663-70
17. Ibànez-Nolla J, Nolla-Salas M, León MA et al. (2004) Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 48:181-192
18. Pfaller MA, Messer SA, Houston A et al.(1998) National epidemiology of mycoses survey: a multicenter study of strain variation and an-tifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 31:289-296
19. Pfaller MA, Jones RN, Messer SA et al.(1998) National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of-Epidemiologic. Diagn Microbiol Infect Dis 30:121-129
20. Pfaller MA, Jones RN, Doern GV et al.(2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 44:747-751
21. Benjamin DK, Jr., DeLong ER, Steinbach WJ et al. (2003) Empirical therapy for neonatal candide-mia in very low birth weight infants. Pediatrics 112:543-547
22. Saiman L, Ludington E, Dawson JD et al. (2001) Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20:1119-1124
23. Bernhardt H, Knoke M (2003) Fakultativ pathogen: Sprosspilze im Gastrointestinaltrakt. Klinikarzt 32:48-52
24. Truss CO (1978) Tissue injury induced by Candida albicans: mental and neurologic manifestations. J Orthomol Psychiatry 7:17-37
25. Truss CO (1980) Restoration of immunologic competence to Candida albicans. J Orthomol Psychiatry 9:287-301
26. Truss CO (1981) The role of Candida albicans in human illness. J Orthomol Psychiatry 10:228-238
27. Truss CO (1984) Metabolic abnormalities in patients with chronic candidiasis: the acetalde-hyde hypothesis. J Orthomol Psychiatry 13:66-93
28. Truss CO (1983) The Missing Diagnosis. The Missing Diagnosis, Inc., Birmingham, Alabama
29. Crook WG (1986) The yeast connection: a medical breakthrough. Professional Books, Jackson, Tennessee
30. Runow KD (1994) Klinische Ökologie. Hippo-krates Verlag, Stuttgart
31. Eis D (2003) Klinische Ökologie. In: Beyer A, Eis D (Hrsg) Praktische Umweltmedizin. Springer Verlag, Berlin, Heidelberg, New York, S 1-35
32. Hauss H, Hauss R (1993) Hefen im Darm - die heimliche Gefahr. Hautnah Mykologie 3:116-117(2-3)
33. Markus HH, Finck H (1995) Candida, der entfesselte Hefepilz. Die versteckte Massenkrankheit und ihre Heilung. Ehrenwirth, München
34. Deutsche Candida-Hilfe e. V., Guzek G, editors (1995) "Am schlimmsten war, daß mich alle für einen Spinner hielten": Pilzinfektionen - Betroffene berichten über eine verkannte Krankheit. medi Verlagsgesellschaft (inzwischen: Promedi-co),Hamburg
35. Guzek G, Lange E (2002) Pilze im Körper - krank ohne Grund? Econ Ullstein List, München
36. Kraske EM (2001) Candida - natürliche Hilfe bei Darmpilzen. Gräfe & Unzer, München
37. Mohr P (2001) Mykosen, die schleichende Krankheit. Oesch, Zürich
38. Kuhlmann D (1991) Die Pilz-Invasion. Gefährliche Hefepilze greifen unser Immunsystem und unsere Gesundheit an. Bio-Medoc-Verlag, Lürschau
39. Costantini AV (1993) Mykotoxine sind die Ursache der Arteriosklerose. Ztg Umweltmed 1:7-8
40. Ionescu G (2001) Langfristige Sanierung der Darmflora. Z Umweltmed 9:340
41. Matejka R (2002) Darmpilze: Tödliche Parasiten oder harmlose Schmarotzer? Naturarzt 142:17/20
42. Sarkisyanz-Heuer H (1996) Candida - Mykose aus der Sicht der Elektroakupunktur nach Voll (EAV). In: Behrendt W, Gerhard I (Hrsg) Naturheilkunde und Umweltmedizin in der Frauenheilkunde. Hippokrates Verlag, Stuttgart, S 33-42
43. Schirmer S (1997) Darmpilze und ihre schweren Folgen. Naturarzt [Heft 7]:6-10
44. Siedentopp U (1993) Candidosen - ignorierte Infektionen. Ztg Umweltmed 1:8-11
45. Steneberg A (1995) Candida albicans-Infektio-nen - keine Modekrankheit. Umwelt und Gesundheit 5:56-60
46. Hauss R (1996) Hefen im Verdauungstrakt. Ein mikrobiologischer Störfall? In: Behrendt W, Gerhard I (Hrsg) NATUM. Naturheilkunde und Umweltmedizin in der Frauenheilkunde. Hippokrates, Stuttgart, S 49-52
47. Peters U, Zimmermann K (1996) Umweltschad-stoffe, Immunsystem und intestinale Sproßpilzbesiedlung. Ztg Umweltmed 4:169-172
48. Sonnenborn U (1998) Die "Pilztherapie" im Widerstreit der Meinungen. Ztg Umweltmed 6:199
49. Weiss T (1996) Candida - Bedrohung oder Marginalie? In: Behrendt W, Gerhard I (Hrsg) NATUM, Naturheilkunde und Umweltmedizin in der Frauenheilkunde. Hippokrates Verlag, Stuttgart, S 43-48
50. Beckmann G, Rüffer A (2000) Mikroökologie des Darmes. Grundlagen, Diagnostik, Therapie. Schlütersche GmbH & Co. KG, Hannover
51. Friedel M, Kohler M (1988) Blähbauch durch Hefen. Therapiewoche 38:3706-3709
52. Hauss R (1990) Intestinalmykose - Provokationsfaktor bei der Nahrungsmittelallergie. In: Ottenjann (Hrsg) Ökosystem Darm II: Mikrobiologie, Immunologie, Morphologie. Klinik und Therapie akuter und chronischer entzündlicher Darmerkrankungen. Ökosystem Darm. Band 2. Springer, Berlin, S 257-261
53. Heizmann WR (2001) Pilze suchen im Intesti-num: Das lohnt sich manchmal doch! Münch med Wschr 143:32-33
54. Heizmann WR, Nolting S (1999) Candida - Intestinaltrakt - Immunsystem - Allergie. Pro-medico, Hamburg
55. Menzel I (1989) Intestinaler Candidabefall als Provokationsfaktor für Neurodermitis. Candida albicans in den Fäzes/candidaspezifische IgE im Serum. In: Müller J, Ottenjann R, Seifert J (Hrsg) Ökosystem Darm. Springer, Berlin-Heidelberg-New York, S 125-131
56. Menzel I (1991) Hauterkrankungen und Störungen der Darmökologie. Notabene Medici 21:332-336
57. Nolting S (Hrsg) (1995) Mykosen des Verdauungstraktes. Medi Verlag, Hamburg
58. Nolting VS, Stanescu-Siegmund A, Schwantes PA (1998) Candida und der Intestinaltrakt. Fortschr Med 116:22-28
59. Rieth H (1991) Gefährliche Irrlehre: Pathogene Hefen seien "normale" Darmbewohner. Pilzdialog [Heft 3]:37
60. Rieth H (1991) Mykosen als Massenerkrankun-gen. Pilzdialog [Heft 4]:53
61. Schulte-Uebbing C (1996) Angewandte Umweltmedizin. Sonntag Verlag, Stuttgart
62. Sonnenborn U (1993) Auswirkungen von Umweltgiften und anderen exogenen Noxen auf Mikroökologie und Immunologie des Gestrointestinaltraktes. Erfahrungsheilkunde 45:46-49
63. Steneberg A (1996) Umweltmedizin. Wissen-schaftliche Buchgesellschaft, Darmstadt
64. Muss C, Drasch G, Roider G et al. (2000) Fördern Edelmetalle aus zahnärztlichen Legierungen den intestinalen Candida-Befall durch suppressive Wirkung auf das darmassoziierte Immunsystem? Z Umweltmed 8:173-175
65. Eis D (2003) Candidabesiedlung, Candidiasis und "Candida- Syndrom". In: Beyer A, Eis D (Hrsg) Praktische Umweltmedizin. Springer Verlag, Berlin, Heidelberg, New York, Sektion 03.22, S 1-35
66. Fenner T (2001) Mykose-Therapie. In: Böse-O'Reilly, Kammerer S, Mersch-Sundermann V et al.(Hrsg) Leitfaden Umweltmedizin. Urban & Fischer, München-Jena, Kap. 3.4, S 100-103
67. Reichl FX (2000) Taschenatlas der Umwelt-medizin. Thieme, Stuttgart
68. Seidel HJ (1998) Praxis der Umweltmedizin. Thieme, Stuttgart
69. Wiesmüller GA, Hornberg C (2002) Candida-Syndrom (CS). In: Dott W, Merk H, Neuser J et al. (Hrsg) Lehrbuch der Umweltmedizin. Wissen-schaftliche Verlagsgesellschaft, Stuttgart, Kap.14.6., S 519-520
70. Eis D, Beckel T, Birkner N et al. (2003) Multizen-trische MCS-Studie: Untersuchungen zur Aufklärung der Ursachen des MCS-Syndroms (Multiple Chemikalienüberempfindlichkeit) bzw.der IEI (idiopathische umweltbezogene Unverträglichkeiten) unter besonderer Berücksichtigung des Beitrages von Umweltchemikalien. In: Umweltbundesamt (Hrsg) WaBoLu-Hefte. Heft 02/03. Umweltbundesamt, Berlin
71. American Academy of Allergy and Immunology - Executive committee [position statements] (1986) Candidiasis hypersensitivity syndrome. J Allergy Clin Immunol 78:271-273
72. Council NR (Hrsg) (1992) Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. National Academy Press, Washington, D.C.
73. Bernhardt H (1996) Candida im Ökosystem des Orointestinaltraktes. Mycoses 39 [Suppl 1]:44-47
74. Bernhardt H (1998) Pilze im Darm - Normalflora oder Erreger? Z Ärztl Fortb Qualitätssich 92:154-156
75. Denning DW (1995) Fortnightly review: Management of genital candidiasis. BMJ 310:1241-1244
76. Eckhardt VF, Rösch W (1995) Pilze im Darm - Krankheitserreger oder Kommensale. Dtsch Ärztebl 92:1552-1553 (auch: A 2324 - A 2326)
77. Knoke M (1996) Klinische Bilder der Candidose im Orointestinaltrakt. Fiktion oder Realität? Mycoses 39 [Suppl 1]:40-43
78. Knoke M (1998) Pilze im Orointestinaltrakt und ihre wissenschaftlich begründete Stellung. Z Ärztl Fortb Qualitätssich 92:157-162
79. Knoke M (1999) Gastrointestinale Mikroökologie des Menschen und Candida. Mycoses 42 [Suppl 1]:30-34
80. Knoke M (2001) Pilze im Darm. Internist Prax 41:163-164
81. Kreisel W (1999) Pilze im Darm - Klinische Bedeutung. Praxis 88:5-10
82. Lembcke B (1999) Pilze im Darm - Gefahr oder Mythos? Eine Herausforderung ärztlicher Redlichkeit. In: Kirchner T, Lembcke B, Kist M (Hrsg) Ökosystem Darm VIII. Springer-Verlag, Berlin, Heidelberg, New York, S 53-63
83. Leonhardt I, Schmitt HJ (1997) Pilze im Darm. Tägl Prax 38:495-496
84. Levine J, Dykoski RK, Janoff EN (1995) Candida-associated diarrhea: a syndrome in search of credibility. Clin Infect Dis 21:881-886
85. Müller J (1993) Besonderheiten von PilzKeimträgern als Dauerausscheider. Zbl Hyg 194:162-172
86. Rösch W (1996) Pilze im Darm aus Sicht des Ga-stroenterologen. Ärztezeitschrift für Naturheilverfahren 37:824-828
87. Rösch W (1996) Pilze im Stuhl, Pilze im Darm - therapeutische Konsequenzen? Versicherungsmedizin 48:215-217
88. Rösch WW (2003) Pilze im Darm (Vortrag), Internistenkongress Wiesbaden 2003 (MMW 145, Nr.27/28, S.10)
89. Sander, A., Kist M (1997) Pilze im Stuhl - Mythen und Fakten. Aus labordiagnostischer Sicht. Kas-senarzt 37:36-38
90. Wedding U, Geiss HK, Theilmann I et al.(1995) Candida-Besiedlung und Befall des Gastroin-testinaltrakts. Dt Ärzteblatt 92:A-3470-A-3478
91. Wedding U, Geiss HK, Theilmann I et al.(1995) Candida species: im Stuhl und im Kolon? Kassenarzt 36:40-42
92. Weig M, Karch H, Mühlschlegel F (1999) Pilze im Darm - Fakten, Fragen, Forschungsbedarf. In: Kirchner T, Lembcke B, Kist M (Hrsg) Ökosystem Darm VIII. Springer, Berlin, Heidelberg, New York, S 65-74
93. Fegeler W (1995) Hefepilznachweis im Stuhl - Aspekte zur Bewertung. Pilzdialog 10 [Heft 3/4]:7-8
94. Seebacher C (1996) Mykophobie - eine neue Krankheit? Mycoses 39 [Suppl 1]:30-32
95. Lacour M, Zunder T, Huber R et al.(2002) The pathogenic significance of intestinal Candida colonization - A systematic review from an interdisciplinary and environmental medical point of view. Int J Hyg Environ Health 205:257-268
96. Cohen R, Roth FJ, Delgado E et al.(1969) Fungal flora of the normal human small and large intestine. New Engl J Med 280:638-641
97. Gorbach SL, Nahas L, Lerner PI et al.(1967) Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 53:845-855
98. Haynes K (2001) Virulence in Candida species. Trends Microbiol 9:591-596
99. Dignani MC, Solomkin JS, Anaissie EJ (2003) Candida. In: Anaissie EJ, McGinnis MR, Pfaller MA (Hrsg) Clinical Mycology. Churchill Living-stone/ Elsevier Science, New York, Edinburgh, London, Philadelphia, S 195-239
100. Schauer F, Hanschke R (1999) Zur Taxonomie und Ökologie der Gattung Candida. Mycoses 42 [Suppl 1]:12-21
101. Kennedy MJ (1989) Regulation of Candida al-bicans populations in the gastrointestinal tract: mechanisms and significance in GI and systemic candidiasis. Curr Top Med Mycol 3:315-402
102. Bernhardt H, Knoke M (1997) Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 32 [Suppl 222]:102-106
103. Bernhardt H, Zimmermann K, Knoke M (1994) Dimorphismus von Candida albicans im Modell der kontinuierlichen Kultur. Mycoses 37 [Suppl 1]:50-56
104. Knoke M, Bernhardt H (1986) Mikroökologie des Menschen. Mikroflora bei Gesunden und Kranken. VCH Verlagsgesellschaft, Weinheim
105. Levy J (2000) The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol 95 [Suppl 1]:8-10
106. Bernhardt H, Wellmer A, Zimmermann K et al. (1995) Wachstum von Candida albicans in normaler und veränderter Fäkalflora im Modell der kontinuierlichen Kultur. Mycoses 38 [Suppl 1]:22-27
107. Bernhardt H, Zimmermann K, Knoke M (1999) The continuous flow culture as an in vitro model in experimental mycology. Mycoses 42 [Suppl 2]:29-32
108. Müller J, Kappe R, Kubitza D et al.(1987)-Endomykosen im Raum Freiburg. Mykosen 30 [Suppl 2]:9-28
109. Höchter W, Seeliger HPR, Keilig W et al.(1983) Pilzbesiedlung bei Kolitiden. Dtsch Med Wschr 108:416-418
110. Vollaard EJ, Clasener HA, Janssen AJ (1992) Cotrimoxazole impairs colonization resistance in healthy volunteers. J Antimicrob Chemother 30:685-691
111. Giuliano M, Barza M, Jacobus NV et al.(1987) Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 31:202-206
112. Krause R, Schwab E, Bachhiesl D et al.(2001) Role of Candida in antibiotic-associated diarrhea. J Infect Dis 184:1065-1069
113. Leigh DA, Walsh BT, Leung A et al.(1990) The effect of cefuroxime axetil on the faecal flora of healthy volunteers. J Antimicrob Chemother 26:261-268
114. Mavromanolakis E, Maraki S, Cranidis A et al. (2001) The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. Scand J Infect Dis 33:477-8
115. Ponnuvel KM, Rajkumar R, Menon T et al. (1996) Role of Candida in indirect pathogenesis of antibiotic associated diarrhoea in infants. Mycopathologia 135:145-147
116. Thomakos N, Maraki S, Liakakos T et al.(1998) Effects of cefamandole, cefuroxime and cefox-itin on yeast fecal flora of surgical patients. Chemotherapy 44:324-327
117. Samonis G, Gikas A, Toloudis P et al. (1994) Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis 13:665-667
118. Högenauer C, Hammer HF, Krejs GJ et al.(1998) Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27:702-710
119. Martinez E, Marcos A (1991) Antibiotic-associated diarrhoea. Lancet 337:911
120. Schmidt A, Nöldechen CF, Mendling W et al. (1997) Einnahme oraler Kontrazeptiva und vaginale Kandidabesiedlung. Zentralbl Gynäkol 119:545-549
121. de Oliveira JM, Cruz AS, Fonseca AF et al.(1993) Prevalence of Candida albicans in vaginal fluid of asymptomatic Portuguese women. J Reprod Med 38:41-42
122. Spinillo A, Pizzoli G, Colonna L et al.(1993) Epi-demiologic characteristics of women with idio-pathic recurrent vulvovaginal candidiasis. Obstet Gynecol 81:721-727
123. Geiger AM, Foxman B (1996) Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 7:182-187
124. Reed BD, Gorenflo DW, Gillespie BW et al. (2000) Sexual behaviors and other risk factors for Candida vulvovaginitis. J Womens Health Gend Based Med 9:645-655
125. Darwazeh AM, MacFarlane TW, McCuish A et al. (1991) Mixed salivary glucose levels and can-didal carriage in patients with diabetes melli-tus. J Oral Pathol Med 20:280-283
126. Dorocka-Bobkowska B, Budtz-Jörgensen E, Wloch S (1996) Non-insulin-dependent diabetes mellitus as a risk factor for denture stomati-tis. J Oral Pathol Med 25:411-415
127. Hedderwick SA, Wan JY, Bradley SF et al.(1998) Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc 46:849-953
128. Willis AM, Coulter WA, Fulton CR et al.(1999) Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16:675-679
129. Nieuwenhuizen WF, Pieters RH, Knippels LM et al. (2003) Is Candida albicans a trigger in the onset of coeliac disease? Lancet 361:2152-2154
130. Jonkers D, Stockbrügger R (2003) Unexplained Diarrhoea, Candida in the Faeces. Aktuel Ernaehr Med 28:87-92
131. Hazra PR, Mohanty GP, Gupta JC (1975) Infantile diarrhoea: a bacteriological and mycological study. Indian Pediatr 12:983-985
132. Talwar P, Chakrabarti A, Chawla A et al.(1990) Fungal diarrhoea: association of different fungi and seasonal variation in their incidence. Myco-pathologia 110:101-105
133. Chaudhury A, Nath G, Shukla B et al.(1996) Diarrhoea associated with Candida spp.: incidence and seasonal variation. J Diarrhoeal Dis Res 14:110-112
134. Middleton SJ, Coley A, Hunter JO (1992) The role of faecal Candida albicans in the patho-genesis of food-intolerant irritable bowel syn-drome. Postgrad Med J 68:453-454
135. Pirone E, Infantino A, Masin A et al.(1992) Can proctological procedures resolve perianal pruritus and mycosis? A prospective study of 23 cases. Int J Colorectal Dis 7:18-20
136. David LM, Walzman M, Rajamanoharan S (1997) Genital colonisation and infection with candida in heterosexual and homosexual males. Genitourin Med 73:394-396
137. Silverman SH, Youngs DJ, Allan A et al. (1989) The fecal microflora in pruritus ani. Dis Colon Rectum 32:466-468
138. Poirier S, Auger P, Joly J et al.(1990) Interest of biotyping Candida albicans in chronic vulvova-ginitis. Mycoses 33:24-28
139. Mendling W, Gutschmidt J, Gantenberg R et al. (1998) Vergleich der Stammspezifität von Hefepilzen verschiedener Lokalisation bei Frauen mit Vaginalcandidosen. Mycoses 41 [Suppl 2]:23-25
140. Mercure S, Poirier S, Lemay G et al.(1993) Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis. J Infect Dis 168:502-507
141. Fong IW (1994) The rectal carriage of yeast in patients with vaginal candidiasis. Clin Invest Med 17:426-431
142. Parsons WL, Godwin M, Robbins C et al.(1993) Prevalence of cervical pathogens in women with and without inflammatory changes on smear testing. BMJ 306:1173-1174
143. Renfro L, Feder HM, Lane TJ et al.(1989) Yeast connection among 100 patients with chronic fatigue. Am J Med 86:165-168
144. Mawle AC, Nisenbaum R, Dobbins JG et al. (1995) Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis 21:1386-1389
145. Kozinn PJ, Taschdjian CL (1962) Enteric candi-diasis. Pediatrics 30:71-85
146. Knoke M, Bernhardt H, Schwesinger G (1981) Darmmykosen. Dtsch Med Wochenschr 106:1238-1239
147. Prescott RJ, Harris M, Banerjee SS (1992) Fungal infections of the small and large intestine. J Clin Pathol 45:806-811
148. Bond S, Stewart DL, Bendon RW (2000) Invasive Candida enteritis of the newborn. J Pediatr Surg 35:1496-1498
149. Krause W, Matheis H, Wulf K (1969) Experimentelle Fungiämie und Fungurie durch orale Verabreichung großer Mengen von Candida albicans beim gesunden Menschen (Selbstversuch). Arzneimittelforschung 19:85-91
150. MacFie J, O'Boyle C, Mitchell CJ et al.(1999) Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45:223-228
151. Pierro A, van Saene HKF, Donnell SC et al. (1996) Microbial translocation in neonates and infants receiving long-term parenteral nutrition. Arch Surg 131:176-179
152. Eaves-Pyles T, Alexander JW (2001) Comparison of translocation of different types of microorganisms from the intestinal tract of burned mice. Shock 16:148-152
153. Gianotti L, Alexander JW, Fukushima R et al. (1993) Translocation of Candida albicans is related to the blood flow of individual intestinal villi. Circ Shock 40:250-257
154. Kim AS, Garni RM, Henry-Stanley MJ et al. (2003) Hypoxia and extraintestinal dissemination of Candida albicans yeast forms. Shock 19:257-262
155. Pappo I, Polacheck I, Zmora O et al.(1994) Altered gut barrier function to Candida during parenteral nutrition. Nutrition 10:151-154
156. Calvo Romero JM, Álvarez Vega JL, Salazar Vallinas JM et al. (1998) Candida arthritis in an immunocompetent patient without predisposing factors. Clin Rheumatol 17:393-394
157. Silveira LH, Cuellar ML, Citera G et al.(1993) Candida arthritis. Rheum Dis Clin North Am 19:427-437
158. Rees JR, Pinner RW, Haijeh RA et al.(1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 27:1138-1147
159. Reid G, Tieszer C, Lam D (1995) Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicans to fibers and epithelial cells. J Ind Microbiol 15:248-253
160. Wagner RD, Pierson C, Warner T et al.(2000) Probiotic effects of feeding heat-killed Lacto-bacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 63:638-644
161. Diebel LN, Liberati DM, Diglio CA et al. (1999) Synergistic effects of Candida and Escherichia coli on gut barrier function. J Trauma 47:1045-1050
162. Vartivarian SE (1992) Virulence properties and nonimmune pathogenetic mechanisms of fun-gi. Clin Infect Dis 14 [Suppl 1]:30-36
163. Shah DT, Jackman S, Engle J et al.(1998) Effect of gliotoxin on human polymorphonuclear neutrophils. Infect Dis Obstet Gynecol 6:168-175
164. Logan BK, Jones AW (2000) Endogenous ethanol 'auto-brewery syndrome'as a drunk-driving defence challenge. Med Sci Law 40:206-215
165. Geertinger P, Bodenhoff J, Helweg-Larsen K et al. (1982) Endogenous alcohol production by intestinal fermentation in sudden infant death. Z Rechtsmed 89:167-172
166. Coleman R, Hay RJ (1997) Chronic mucocutaneous candidosis associated with hypothyroid-ism: a distinct syndrome? Br J Dermatol 136:24-29
167. Cater RE (1995) Chronic intestinal candidiasis as a possible etiological factor in the chronic fatigue syndrome. Med Hypotheses 44:507-515
168. Rotstein D, Parodo J, Taneja R et al.(2000) Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock 14:278-283
169. Fidel jr. PL, Sobel JD (1994) The role of cellmediated immunity in candidiasis. Trends Microbiol 2:202-206
170. Nawrot U, Grzybek-Hryncewicz K, Zielska U et al.(2000) The study of cell-mediated immune response in recurrent vulvovaginal candidiasis. FEMS Immunol Med Microbiol 29:89-94
171. Talluri G, Marella VK, Shirazian D et al.(1999) Immune response in patients with persistent candiduria and occult candidemia. J Urol 162:1361-1364
172. Tokunaka K, Ohno N, Adachi Y et al.(2000) Immunopharmacological and immunotoxicological activities of a water-soluble (1->3)-beta-D-glucan, CSBG from Candida spp. Int J Im-munopharmacol 22:383-394
173. Coogan MM, Sweet SP, Challacombe SJ (1994) Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62:892-896
174. Petitpierre M, Gumowski P, Girard JP (1985) Irritable bowel syndrom and hypersensitivity to food. Ann Allergy 54:538-540
175. Savolainen J, Koivikko A, Kalimo K et al. (1990) IgE, IgA and IgG antibodies and delayed skin response towards Candida albicans antigens in atopics with and without saprophytic growth. Clin Exp Allergy 20:549-554
176. Akiyama K, Shida T, Yasueda H et al.(1994) Atopic asthma caused by Candida albicans acid protease: case reports. Allergy 49:778-781
177. Nermes M, Savolainen J, Kalimo K et al. (1994) Determination of IgE antibodies to Candida albicans mannan with nitrocellulose-RAST in patients with atopic diseases. Clin Exp Allergy 24:318-323
178. Akiyama K, Shida T, Yasueda H et al. (1996) Allergenicity of acid protease secreted by Candida albicans. Allergy 51:887-892
179. Matsumura N, Aiba S, Tanaka M et al.(1997) Comparison of immune reactivity profiles against various environmental allergens between adult patients with atopic dermatitis and patients with allergic respiratory diseases. Acta Derm Venereol (Stockh) 77:388-391
180. Savolainen J, Kortekangas-Savolainen O, Nermes M et al.(1998) IgE, IgA, and IgG responses to common yeasts in atopic patients. Allergy 53:506-512
181. Scalabrin DMF, Bavbek S, Perzanovski MS et al. (1999) Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 104:1273-1279
182. Kimura M, Tsuruta S, Yoshida T (2000) IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis. Int Arch Allergy Immunol 122:195-199
183. Doekes G, van Ieperen-van Dijk AG (1993) Allergens of Pityrosporum ovale and Candida albicans: I. Cross-reactivity of IgE-binding components. Allergy 48:394-400
184. Kortekangas-Savolainen O, Kalimo K, Lammintausta K et al. (1993) IgE-binding components of baker's yeast (Saccharomyces cerevisiae) recognized by immunoblotting analysis. Simultaneous IgE binding to mannan and 46-48 kD allergens of Saccharomyces cerevisiae and Candida albicans. Clin Exp Allergy 23:179-184
185. Huang X, Johansson SGO, Zargari A et al. (1995) Allergen cross-reactivity between Pityrosporum orbiculare and Candida albicans. Allergy 50:648-656
186. Seebacher C (1999) Candida in der Dermatologie. Mycoses 42 [Suppl 1]:63-67
187. Buslau M, Menzel I, Holzmann H (1990) Fungal flora of human faeces in psoriasis and atopic dermatitis. Mycoses 33:90-94
188. Henseler T, Tausch I (1997) Mykosen bei Patienten mit Psoriasis oder atopischer Dermatitis. Mycoses 40 [Suppl 1]:22-28
189. Moraes PS (1998) Recurrent vaginal candidiasis and allergic rhinitis: a common association. Ann Allergy Asthma Immunol 81:165-169
190. Danna PL, Urban C, Bellin E et al.(1991) Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet 337:511-514
191. Brabander JOW, Blank F, Butas CA (1957) Intestinal moniliasis in adults. Can Med Assoc J 77:478-483
192. Sappington TS, McCarten WG, Hartman CL (1963) Diarrhea and Candida albicans infestation of the colon. Med Ann DC 32:48-50
193. Nystatin Multicenter Study Group (1986) Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Am J Obstet Gynecol 155:651-655
194. Spinillo A, Carratta L, Pizzoli G et al.(1992) Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 37:343-347
195. Dismukes WE, Wade JS, Lee JY et al.(1990) A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. N Engl J Med 323:1717-1723
196. Bäck O, Scheynius A, Johansson SG (1995) Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 287:448-451
197. Morita E, Hide M, Yoneya Y et al.(1999) An assessment of the role of Candida albicans antigen in atopic dermatitis. J Dermatol 26:282-287
198. Mitteilung der Kommission "Methoden und Qualitätssicherung in der Umweltmedizin" am Robert Koch-Institut (2001) Grundsätze der Bewertung von umweltmedizinischen Methoden. Bundesgesundheitsblatt 44:519-522